NRx Pharmaceuticals, Inc. (NRXP) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$189
Total Return
-98.11%
CAGR
-54.80%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.27% |
| Median | -7.52% |
| Best | +328.57% |
| Worst | -65.65% |
| % of Windows Positive | 41.1% |
1-Year (252 Trading Days)
| Average | -33.31% |
| Median | -49.45% |
| Best | +169.09% |
| Worst | -97.84% |
| % of Windows Positive | 20.7% |
3-Year (756 Trading Days)
| Average | -79.07% |
| Median | -83.86% |
| Best | -31.05% |
| Worst | -99.03% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -99.53% |
| Average Drawdown | -92.33% |
| Drawdown Duration | 1220 Trading Days (Unrecovered) |
| Sortino Ratio | -0.01 |
| Calmar Ratio | -0.55 |
| CVaR (5%) | -14.99% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +49.45% (+159.33% ann.) | +$4944.91 | $0.00 | $0.00 | $0.00 |
| 2025 | +23.18% | +$2317.93 | $0.00 | $0.00 | $0.00 |
| 2024 | -52.17% | $5217.36 | $0.00 | $0.00 | $0.00 |
| 2023 | -58.56% | $5855.83 | $0.00 | $0.00 | $0.00 |
| 2022 | -76.78% | $7677.83 | $0.00 | $0.00 | $0.00 |
| 2021 | -80.41% | $8040.98 | $0.00 | $0.00 | $0.00 |
| 2020 | +130.19% | +$13018.86 | $0.00 | $0.00 | $0.00 |
| 2019 | +3.92% | +$392.16 | $0.00 | $0.00 | $0.00 |
| 2018 | +5.37% | +$537.19 | $0.00 | $0.00 | $0.00 |
| 2017 partial | +0.83% (+12.89% ann.) | +$83.33 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | December 4, 2017 – February 19, 2020 | +10.77% | +4.74% | +$1077.08 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | +0.81% | +9.63% | +$80.88 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -0.28% | -0.45% | $27.86 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -24.58% | -23.48% | $2458.10 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -86.98% | -88.52% | $8697.60 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -81.41% | -59.65% | $8140.63 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +150.00% | +71.12% | +$15000.30 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.